Approval · Notice of Compliance 4519 · 1996
DIARR-EZE: Notice of Compliance 4519
Issued September 16, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4519
- Date
- September 16, 1996
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- New dosage form
- Therapeutic class
- Antidiarrheal
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIARR-EZE | 02229552 | Cancelled Post Market |
Medicinal ingredients
- LOPERAMIDE HCL 2 MG per TAB